INDIANAPOLIS (AP) - Eli Lilly & Co. says it will pay $62 million to resolve investigations into the marketing and promotion of its anti-psychotic drug Zyprexa in 32 states and Washington, D.C.
The payments will be divided between the states, including Indiana, that were investigating the company. Zyprexa will continue to be available through Medicare programs in all states, and Lilly says there was no finding it had broken any laws.
The company also agreed to provide the states' attorneys general with information about the compensation it paid to health care professionals for promotional speaking or consulting regarding Zyprexa.
Lilly is also being sued by 11 other states not included in Tuesday's settlement.
(Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)